I am taking a positive stance on this suspension. Senior management would know the results. If they were under the anticipated level of previous studies they would have released them by now. They are waiting, which to me means positive news. Maybe they are forging ahead with FDA submissions/negotiations so there will be a double whammy of good news.
Ann: Voluntary Suspension, page-61
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #